Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 4 (2007), Issue 2 (February)

1. Sex differences in postnatal growth and renal development in offspring of rabbit mothers with chronic secondary hypertension.
   Am J Physiol Regul Integr Comp Physiol, 292(2): R706-14. [Abstract] [Full-text]
2. Road traffic noise and hypertension.
   Occup Environ Med, 64(2): 122-6. [Abstract] [Full-text]
3. Naturally occurring hypertension in New World nonhuman primates: Potential role of the perifornical hypothalamus.
   Am J Physiol Regul Integr Comp Physiol, 292(2): R937-45. [Abstract] [Full-text]
4. Sequential growth of fetal sheep cardiac myocytes in response to simultaneous arterial and venous hypertension.
   Am J Physiol Regul Integr Comp Physiol, 292(2): R913-9. [Abstract] [Full-text]
5. Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus.
   Am J Physiol Regul Integr Comp Physiol, 292(2): R736-42. [Abstract] [Full-text]
6. Impact of androgen-induced oxidative stress on hypertension in male SHR.
   Am J Physiol Regul Integr Comp Physiol, 292(2): R731-5. [Abstract] [Full-text]
7. Testosterone contributes to marked elevations in mean arterial pressure in adult male intrauterine growth restricted offspring.
   Am J Physiol Regul Integr Comp Physiol, 292(2): R758-63. [Abstract] [Full-text]
8. Sexual dimorphism in oxidant status in spontaneously hypertensive rats.
   Am J Physiol Regul Integr Comp Physiol, 292(2): R764-8. [Abstract] [Full-text]
9. Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload.
   Biochem Biophys Res Commun, 354(2): 552-8. [Abstract] [Full-text]
10. The eye in hypertension.
    Lancet, 369(9559): 425-35. [Abstract] [Full-text]
11. Strain rate imaging differentiates hypertensive cardiac hypertrophy from physiologic cardiac hypertrophy (athlete's heart).
    J Am Soc Echocardiogr, 20(2): 151-7. [Abstract] [Full-text]
12. Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipine-based treatment: a VALUE substudy.
    J Hypertens, 25(3): 707-12. [Abstract] [Full-text]
13. Rates and determinants of reinitiating antihypertensive therapy after prolonged stoppage: a population-based study.
    J Hypertens, 25(3): 689-97. [Abstract] [Full-text]
14. Impaired renal haemodynamic response to L-arginine in essential hypertension: role of buffering anion and tubuloglomerular feedback.
    J Hypertens, 25(3): 679-88. [Abstract] [Full-text]
15. Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis.
    J Hypertens, 25(3): 663-70. [Abstract] [Full-text]
16. Total peripheral resistance responsiveness during the development of secondary renal hypertension in dogs.
    J Hypertens, 25(3): 649-62. [Abstract] [Full-text]
17. Interactions between aldosterone and connective tissue growth factor in vascular and renal damage in spontaneously hypertensive rats.
    J Hypertens, 25(3): 629-38. [Abstract] [Full-text]
18. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma.
    J Hypertens, 25(3): 619-27. [Abstract] [Full-text]
19. Small artery elasticity assessed by pulse wave analysis is no measure of endothelial dysfunction.
    J Hypertens, 25(3): 571-6. [Abstract] [Full-text]
20. Heritability of blood pressure traits and the genetic contribution to blood pressure variance explained by four blood-pressure-related genes.
    J Hypertens, 25(3): 565-70. [Abstract] [Full-text]
21. SAH gene variants are associated with obesity-related hypertension in Caucasians: the PEGASE Study.
    J Hypertens, 25(3): 557-64. [Abstract] [Full-text]
22. The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients.
    J Hypertens, 25(3): 551-6. [Abstract] [Full-text]
23. Job strain in men, but not in women, predicts a significant rise in blood pressure after 6.5 years of follow-up.
    J Hypertens, 25(3): 525-31. [Abstract] [Full-text]
24. Incidence and predictors of hypertension over 8 years among Chinese men and women.
    J Hypertens, 25(3): 517-23. [Abstract] [Full-text]
25. The GNB3 C825T polymorphism and essential hypertension: a meta-analysis of 34 studies including 14,094 cases and 17,760 controls.
    J Hypertens, 25(3): 487-500. [Abstract] [Full-text]
26. Disaster-related stress as a prospective risk factor for hypertension in parents of adolescent fire victims.
    Am J Epidemiol, 165(4): 410-7. [Abstract] [Full-text]
27. Discordant response of glutathione and thioredoxin systems in human hypertension?
    Antioxid Redox Signal, 9(4): 507-14. [Abstract] [Full-text]
28. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study.
    Blood, 109(4): 1765-72. [Abstract] [Full-text]
29. Endogenous angiotensin II enhances atherogenesis in apoprotein E-deficient mice with renovascular hypertension through activation of vascular smooth muscle cells.
    Life Sci, 80(11): 1057-63. [Abstract] [Full-text]
30. The (pro)renin receptor: pathophysiological roles in cardiovascular and renal pathology.
    Curr Opin Nephrol Hypertens, 16(2): 129-33. [Abstract] [Full-text]
31. The emerging role of angiotensin-converting enzyme-2 in the kidney.
    Curr Opin Nephrol Hypertens, 16(2): 116-21. [Abstract] [Full-text]
32. Role of endothelial-derived nitric oxide in hypertension and renal disease.
    Curr Opin Nephrol Hypertens, 16(2): 105-10. [Abstract] [Full-text]
33. Vascular signaling through cholesterol-rich domains: implications in hypertension.
    Curr Opin Nephrol Hypertens, 16(2): 90-104. [Abstract] [Full-text]
34. Clinical trials in nephrology: success or failure.
    Curr Opin Nephrol Hypertens, 16(2): 59-63. [Abstract] [Full-text]
35. Methods for dealing with discrepant records in linked population health datasets: a cross-sectional study.
    BMC Health Serv Res, 7: 12. [Abstract] [Full-text]
36. Risk index for perioperative renal dysfunction/failure: critical dependence on pulse pressure hypertension.
    Circulation, 115(6): 733-42. [Abstract] [Full-text]
37. Role of oxidative stress on pathogenesis of hypertensive cerebrovascular lesions.
    Pathol Int, 57(3): 133-9. [Abstract] [Full-text]
38. Sitaxsentan in the management of pulmonary arterial hypertension.
    Am J Health Syst Pharm, 64(4): 363-8. [Abstract] [Full-text]
39. Inactivation of extracellular superoxide dismutase contributes to the development of high-volume hypertension.
    Arterioscler Thromb Vasc Biol, 27(3): 470-7. [Abstract] [Full-text]
40. Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects.
    Arterioscler Thromb Vasc Biol, 27(3): 556-63. [Abstract] [Full-text]
41. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy.
    Epidemiology, 18(2): 234-9. [Abstract] [Full-text]
42. Surrogate estimates of insulin sensitivity in subjects with hypertension.
    J Hum Hypertens, 21(3): 246-52. [Abstract] [Full-text]
43. Urinary albumin excretion is associated with impaired flow- and nitroglycerin-mediated brachial artery dilatation in hypertensive adults.
    J Hum Hypertens, 21(3): 231-8. [Abstract] [Full-text]
44. Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients.
    J Hum Hypertens, 21(3): 220-4. [Abstract] [Full-text]
45. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension.
    J Hum Hypertens, 21(3): 212-9. [Abstract] [Full-text]
46. Impacts of diabetes and hypertension on the risk of hospitalization among less educated people.
    J Hum Hypertens, 21(3): 225-30. [Abstract] [Full-text]
47. The effect of gender on the sympathetic nerve hyperactivity of essential hypertension.
    J Hum Hypertens, 21(3): 239-45. [Abstract] [Full-text]
48. Role of N-acetyl-seryl-aspartyl-lysyl-proline in the antifibrotic and anti-inflammatory effects of the angiotensin-converting enzyme inhibitor captopril in hypertension.
    Hypertension, 49(3): 695-703. [Abstract] [Full-text]
49. Lack of macrophage migration inhibitory factor regulation is linked to the increased chronotropic action of angiotensin II in SHR neurons.
    Hypertension, 49(3): 528-34. [Abstract] [Full-text]
50. Functional polymorphism of the Anpep gene increases promoter activity in the Dahl salt-resistant rat.
    Hypertension, 49(3): 467-72. [Abstract] [Full-text]
51. Multiple biomarkers and the risk of incident hypertension.
    Hypertension, 49(3): 432-8. [Abstract] [Full-text]
52. Increased susceptibility to atrial tachyarrhythmia in spontaneously hypertensive rat hearts.
    Hypertension, 49(3): 498-505. [Abstract] [Full-text]
53. Genetic susceptibility to essential hypertension: insight from angiotensinogen.
    Hypertension, 49(3): 597-603. [Abstract] [Full-text]
54. High-resolution mapping for essential hypertension using microsatellite markers.
    Hypertension, 49(3): 446-52. [Abstract] [Full-text]
55. Ala92 type 2 deiodinase allele increases risk for the development of hypertension.
    Hypertension, 49(3): 461-6. [Abstract] [Full-text]
56. Left ventricular mass, blood pressure, and lowered cognitive performance in the Framingham offspring.
    Hypertension, 49(3): 439-45. [Abstract] [Full-text]
57. Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment.
    Hypertension, 49(3): 506-10. [Abstract] [Full-text]
58. Genome-wide linkage mapping for valve calcification susceptibility loci in hypertensive sibships: the Hypertension Genetic Epidemiology Network Study.
    Hypertension, 49(3): 453-60. [Abstract] [Full-text]
59. Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy.
    Hypertension, 49(3): 473-80. [Abstract] [Full-text]
60. Identification of active central nervous system sites in renal wrap hypertensive rats.
    Hypertension, 49(3): 653-8. [Abstract] [Full-text]
61. Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice.
    Hypertension, 49(3): 672-8. [Abstract] [Full-text]
62. Neurons of the rostral ventrolateral medulla contribute to obesity-induced hypertension in rats.
    Hypertension, 49(3): 640-6. [Abstract] [Full-text]
63. Association of adrenal steroids with hypertension and the metabolic syndrome in blacks.
    Hypertension, 49(3): 704-11. [Abstract] [Full-text]
64. Chronic hypertension enhances the postsynaptic effect of baclofen in the nucleus tractus solitarius.
    Hypertension, 49(3): 659-63. [Abstract] [Full-text]
65. Bradykinin B(2) receptor does not contribute to blood pressure lowering during AT(1) receptor blockade.
    J Pharmacol Exp Ther, 320(3): 1261-7. [Abstract] [Full-text]
66. Association of endothelial nitric oxide synthase gene G894T polymorphism with essential hypertension in an adult Pakistani Pathan population.
    Int J Cardiol, 116(1): 113-5. [Abstract] [Full-text]
67. Cardio-cerebrovascular complications in elderly with diabetes.
    Arch Gerontol Geriatr, 44(3): 261-9. [Abstract] [Full-text]
68. Target organ damage in hypertensive patients of different ethnic groups.
    Int J Cardiol, 116(2): 219-24. [Abstract] [Full-text]
69. Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol.
    Int J Cardiol, 116(2): 206-11. [Abstract] [Full-text]
70. Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study.
    Am J Epidemiol, 165(5): 541-52. [Abstract] [Full-text]
71. Prehypertension and cardiovascular disease risk in the Women's Health Initiative.
    Circulation, 115(7): 855-60. [Abstract] [Full-text]
72. Family history of hypertension is not an independent genetic factor predisposing to ischemic stroke subtypes.
    Clin Neurol Neurosurg, 109(3): 247-9. [Abstract] [Full-text]
73. The comparative effects of intravenous nicardipine and prostaglandin E1 on the cerebral pial arteriolar constriction seen after unclamping of an aortic cross-clamp in rabbits.
    Anesth Analg, 104(3): 659-65. [Abstract] [Full-text]
74. Dehydrated hereditary stomatocytosis mimicking familial hyperkalaemic hypertension: clinical and genetic investigation.
    Eur J Haematol, 78(3): 253-9. [Abstract] [Full-text]
75. Exercise-induced hypertension, endothelial dysfunction, and coronary artery disease in a marathon runner.
    Am J Cardiol, 99(5): 743-4. [Abstract] [Full-text]
76. Comparison of ambulatory blood pressure and Task Force criteria to identify pediatric hypertension.
    Pediatr Nephrol, 22(4): 554-8. [Abstract] [Full-text]
77. Blood pressure control in pediatric hemodialysis: the Midwest Pediatric Nephrology Consortium Study.
    Pediatr Nephrol, 22(4): 547-53. [Abstract] [Full-text]
78. Developmental origins of adult hypertension: new insights into the role of the kidney.
    Pediatr Nephrol, 22(4): 490-5. [Abstract] [Full-text]
79. C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice.
    Circulation, 115(8): 1020-8. [Abstract] [Full-text]
80. Low-grade inflammation is a risk factor for clinical stroke events in addition to silent cerebral infarcts in Japanese older hypertensives: the Jichi Medical School ABPM Study, wave 1.
    Stroke, 38(3): 911-7. [Abstract] [Full-text]
81. Size at birth and blood pressure in early adolescence: a prospective birth cohort study.
    Am J Epidemiol, 165(6): 611-6. [Abstract] [Full-text]
82. Favourable effects of nilvadipine on cognitive function and regional cerebral blood flow on SPECT in hypertensive patients with mild cognitive impairment.
    Nucl Med Commun, 28(4): 281-7. [Abstract] [Full-text]
83. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions.
    Clin Sci (Lond), 112(7): 375-84. [Abstract] [Full-text]

© 2004-2008 Hypertension Research Today. All Rights Reserved.